Speaker(s): 

Matthew Bauer, BSN - nothing to disclose

Shikhar Agarwal, MD - nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• ECMO updates of Q1/2 2025
• New mode of ECMO cannulation (LAVA ECMO)
• Program update/possible clinical trial 
• Cardiogenic Shock team activation outcomes

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Matthew Bauer, BSN, MCS, Jeremy Patterson, DO, and Jason Stamm MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant.